Revenue soars but volume modest; margin recovery on track via product mix shift
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met revenue guidance (+25.6% vs. +20%+ expected), margin guidance revised up (1-1.5%→2-2.5%), capex on track. Volume miss vs. prior double-digit aspiration (only 5.5%).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue growth (+25.6%) and margin recovery story (11.5-12% EBITDA guidance, GVT mix shift to 65-70%) are credible and supported by capex execution. However, Q2 volume of only 5.5% and industry export decline (-31%) mean near-term growth is price/mix-driven, not volume-driven. South plant upside is 12-18 months away. Hold pending Q3 volume acceleration.
₹860.6 Cr
Revenue · +25.6% YoY₹41.6 Cr
Reported PAT · +237.6% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue growth 25%, volume 5.5%
METDelivered ₹860.6 Cr (+25.6% YoY), volume +5.5% confirms management claim; price/mix outpaced volume
EBITDA 11.7% due to better utilization and improved JVs
METDelivered OPM 11.3%, EBITDA claim 11.7% is plausible (EBITDA > OPM); JVs swung from ₹12 Cr loss to ₹3 Cr profit in Q2
GVT mix now 45%, targeting 65-70% via South plant
MET45% current mix stated in call; South plant all-GVT expansion (16 million sq m) is credible mechanism. Not contradicted by Q2 numbers.
Gas prices ₹70/SCM, full pass-through achieved, 16-17% price increase April-now
METQ2 revenue +25.6% with only 5.5% volume = ~19% price/mix uplift; consistent with gas pass-through claim
Morbi exports down 31%, but Somany tiles +25%
METIndustry export headwind -31.2%, Somany breakup tiles +25% (₹723 Cr), is internally consistent. Export decline is real headwind despite domestic strength.
Earnings quality
What changed since the last call
EBITDA margin guidance raised
UpgradePrior call: 1-1.5% FY27 margin improvement over FY26. This call: revised to 2-2.5% improvement, with FY27 target 11.5%-12%.
South capex structure refined
NeutralOriginal: ₹275 Cr capex FY27-28, 65-70% equity-funded. Revised: ₹250 Cr South + ₹60 Cr Somany side + routine modernization, 50-50 debt-equity.
Volume growth reset lower
DowngradeQ2 volume only 5.5% (vs. prior 'double-digit' aspiration). Management now guides 7-8% Q3, single-digit FY27. Export headwind (-31% industry) blamed.
JV profitability turned
UpgradeQ2 prior year: ₹12 Cr loss. Q2 this year: ₹3 Cr profit. H1 swing from ₹23 Cr loss to ₹6 Cr profit. Positive inflection.
The Q&A
Analysts probed volume growth disappointment (5.5% in a +25% revenue quarter), Morbi crisis impact, gas pricing floor, and GVT ramp timeline. Management defended single-digit volume as expected, blamed export headwind & maintenance disruptions, addressed gas floor (tiles still cost-competitive), and confirmed South plant Sept 2027 production. No aggressive pushback; management held its guidance confidently.
Pricing sustainability & gas pass-through — Nilesh Sharma, Monomer Capital
PartialGas already down INR2-3 from peak April; further declines unlikely. Price increases are mix of gas + other costs. Full pass-through achieved. Gas currently ₹70/SCM, unlikely to spike further.
GVT mix & capex plans — Sagnik Sarkar, SKP Securities
AnsweredGVT 45% now (up from 41%). Next 16M sq m all GVT; will hit 65-70% in 2-3 years. GVT higher margin but not a standalone lever; benefit is volume absorption + mix shift together.
Capacity utilization & gas pricing floor — Divaneet Savla, Savia Family Office
Answered100% capacity utilization. Even if tiles prices rise 50% from current, still viable vs. alternatives. Gas supply not constrained. No viability threshold identified.
Volume growth trajectory & segment mix — Sneha, Nuvama
Answered5.5% Q2 due to maintenance disruptions (20 days July, 15 days Aug). Expect 7-8% Q3. No double-digit guidance. Sanitaryware +20%, building solutions +28% (both high-margin, expanding capacity Sep 2027).
Medium to long-term margin trajectory — Shruti Mulchandani, Ikigai Asset Management
PartialFY27 guidance 11.5-12% EBITDA. FY28-29 room for improvement. JVs will contribute positively (no margin drag next year). GVT capex accretive. 3-year view: upwards trajectory but not specifying number.
Bathware margins & pricing power — Karan Bhatelia, Asian Markets Securities
AnsweredBathware margins high & stable (couple bits above tiles). Q1 was drag (brass prices shot up); Q2 better. Project 4% hike is volume-based, realized 1.5% via pass-on + pricing. Mix shift to projects (+4%) and adhesive (+40-50% growth) adds 2% EBITDA margin spread over time.
Capacity post-South plant expansion — Bharat Kudikyala, Choice Institutional Equities
AnsweredFY27 sales target 79-80M sq m. FY28 (mid-year South online) adds 10-11M sq m. Total capacity ~90M sq m by end FY28.
Guidance
FY27 'high single digits' growth (post-H1 completion)
MediumH1 growth 25.6% YoY, but export headwind & volume moderation (5.5% Q2) suggest FY27 tapers. Mid-teens growth estimate, not 25%+ sustained.
Sales target FY27: 79-80M sq m; FY28 (with South): 10-11M sq m addition
HighSpecific, operational target. South plant capex on track, Sept 2027 firing (production). Credible.
FY27 EBITDA margins 11.5%-12% (raised from prior 1-1.5% improvement guidance)
HighQ2 achieved 11.7%; trajectory to 12% by year-end is incremental but credible via mix (GVT +4%, JV profit recovery).
FY28-29 margins upwards of 11.5%-12%, with room for improvement
MediumSouth plant adds all-GVT capacity; margin accretive. But specific 13%+ target not given; deferred as multi-year story.
Sanitaryware & building solutions expand 20-28%; push 22-25% of total revenue in 2-3 years (from 16-17% now)
MediumGrowth rates proven in Q2, but high-margin products are low-absolute-volume currently. Margin contribution is real but gradual.
South capex ₹250 Cr (50-50 debt-equity); Somany side ₹60 Cr capex + routine modernization (Sudha ₹15 Cr, Vintage ₹8 Cr)
HighDetailed, on-track. Sept 2027 production deadline for South plant. Revised from original ₹275 Cr guidance but still in neighborhood.
Routine capex ₹70-80 Cr/year (Somany standalone) for debottlenecking & modernization
HighAnnually funded from internal accruals per management statement.
Risks the call surfaced
Geopolitical export headwind
MediumMorbi (export hub) 35-45% shut due to Ukraine war impact on freight & land prices. Industry exports down 31.2%. Recovery timeline uncertain, dependent on geopolitical thaw.
Volume growth deceleration
MediumQ2 volume only 5.5% despite 25.6% revenue growth. Price/mix (+19%) outpaced volume growth. Management resets guidance to 7-8% Q3, single-digit FY27. Risk: volume may remain pressured if demand weakens post-Diwali.
Gas price volatility
LowGas currently ₹70/SCM (up from ₹45 in FY26). Full pass-through achieved in Q2 (+16-17% pricing), but future spikes could hit margins if pricing power caps. War escalation risk remains.
South plant capex execution
Medium₹250 Cr South capex for 16M sq m GVT expansion, targeted Sept 2027 production. Delay would push capacity ramp & GVT mix upside to FY29, delaying margin expansion & volume scale.
JV profitability sustainability
LowQ2 prior: ₹12 Cr loss. Q2 current: ₹3 Cr profit. This swing inflates PAT growth (+237.6% YoY). Risk: if JV margins revert to loss, PAT would be heavily impacted. Exposure: ~₹3-6 Cr H1 swing is ~7-15% of Somany consolidated profit.
Management
Score 8/10. Clear & transparent on headwinds (Morbi export crisis, gas volatility, volume moderation). Detailed on capex plans (₹250 Cr South, Sept 2027 firing). Addresses analyst probes directly (capacity, pricing, GVT mix). No evasion detected. Acknowledges constraints (war, freight rates, volume cap at 5.5% this quarter) candidly. Revenue guidance met (+25.6% YoY vs. +20%+ expected). Margin guidance revised up (1-1.5% → 2-2.5%), now tracking 11.5-12% EBITDA for FY27. Capex on track (South plant Sept 2027 deadline credible). Volume guidance reset lower (double-digit aspiration → 5.5% Q2, 7-8% Q3) but execution honest.
1 · Q3 FY27 (Dec 2026)
Volume acceleration to 7-8%; export recovery post-Diwali/geopolitical relief
2 · Sept 2027 (FY28)
South plant ramp (16M sq m GVT capacity), GVT mix jump 45%→50%+
3 · FY28-29
GVT mix 65-70% achieved; margin target 12%+ via mix + capacity absorption
Hold pending Q3 volume acceleration.
Informational and educational content only. Not investment advice.